v3.26.1
Loans and borrowings (Details 2)
₨ in Millions, $ in Millions
Mar. 31, 2026
INR (₨)
Mar. 31, 2026
USD ($)
Mar. 31, 2025
INR (₨)
Current portion      
Current portion of non-current borrowings ₨ 6,003 $ 64 ₨ 857
Non-current portion      
Rupee term loan from bank to the APSL subsidiary 12,203 $ 130 7,864
Non-convertible debentures by the APSL subsidiary [Member]      
Current portion      
Current portion of non-current borrowings [1] 3,799   0
Non-current portion      
Rupee term loan from bank to the APSL subsidiary [1] 0   3,800
Obligations Under Leases [Member]      
Current portion      
Current lease liabilities [2] 2,204   857
Non-current portion      
Obligations under leases [2] ₨ 12,203   ₨ 4,064
[1] The Rupee term loan obtained from a bank by the Company’s subsidiary, Aurigene Pharmaceutical Services Limited is subject to certain covenants that are required to be maintained on a consolidated basis during the period of the loan. The covenant is to be tested on an annual basis at the end of each financial year. As at March 31, 2026 and March 31, 2025, the Company is in compliance with the covenants and has no indication that it will have difficulty in complying with the same.
[2] Refer to Note 11.B of these consolidated financial statements for further details.